DICE Therapeutics, Inc. - Common Stock (NQ:DICE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 8, 2023 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	47.45 (10)
Ask (Size)	47.81 (2)
Prev. Close	47.55
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	47,790,092
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BioMedNewsBreaks — BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Positioned Favorably with Worldwide License to Anti-IL-17 NanoAbs

September 01, 2023

Via Investor Brand Network

Why These 3 Large Caps Are Bucking the August Slump

August 22, 2023

The three largest S&P 500 outperformers of August are tacking on gains in a weak market, making them intriguing momentum plays to watch for the rest of 2023.

Via MarketBeat

Performance

More News

What 9 Analyst Ratings Have To Say About DICE Therapeutics ↗

August 09, 2023

Via Benzinga

Analyst Expectations for DICE Therapeutics's Future ↗

June 20, 2023

Via Benzinga

Health Care Company Eli Lilly Announces Acquisition of DICE Therapeutics ↗

June 20, 2023

Via Benzinga

Top 5 Health Care Stocks That May Crash In Q3 ↗

August 07, 2023

Via Benzinga

Eli Lilly To Report Q2 Earnings: What's In The Cards? ↗

August 05, 2023

Via Talk Markets

M&A Activity, Booming Sales of Anti-IL-17 Drugs Suggest Strong Upside Potential for BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

July 26, 2023

Via Investor Brand Network

MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022 ↗

July 17, 2023

Via Benzinga

DICE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE

July 10, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Why Shares of Ventyx Biosciences Rose Monday ↗

July 03, 2023

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023 ↗

June 26, 2023

Via Benzinga

Stock Market Pulls Back After Several Weeks Of Gains: Weekly Review ↗

June 23, 2023

Via Investor's Business Daily

Why Dice Therapeutics Stock Bolted Higher This Week ↗

June 22, 2023

Via The Motley Fool

Is Eli Lilly's Dice Therapeutics Acquisition a Needle-Moving Event? ↗

June 21, 2023

Via The Motley Fool

DICE THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE

June 21, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2023 ↗

June 21, 2023

Via Benzinga

Red Hot Eli Lilly Rolls the DICE With Its Latest Biotech Takeover

June 21, 2023

Via MarketBeat

Eli Lilly's $2.4 Billion Acquisition of Dice Therapeutics: What Investors Need to Know ↗

June 20, 2023

Via The Motley Fool

Crude Oil Down 2%; Dragonfly Energy Shares Plunge ↗

June 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 20, 2023

Via Benzinga

Dow Dips Over 300 Points; DICE Therapeutics Shares Spike Higher ↗

June 20, 2023

Via Benzinga

Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 20, 2023

Via Benzinga

Eli Lilly (NYSE: LLY) Acquires DICE Therapeutics (NASDAQ: DICE): A New Step in Autoimmune Disease Treatments

June 20, 2023

Via Spotlight Growth

Why Shares of Dice Therapeutics Are Skyrocketing Tuesday ↗

June 20, 2023

Via The Motley Fool

Frequently Asked Questions

Is DICE Therapeutics, Inc. - Common Stock publicly traded?

Yes, DICE Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does DICE Therapeutics, Inc. - Common Stock trade on?

DICE Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for DICE Therapeutics, Inc. - Common Stock?

The ticker symbol for DICE Therapeutics, Inc. - Common Stock is DICE on the Nasdaq Stock Market